CONSERVED SOLVENT NETWORKS in GPCR ACTIVATION by ELISE

Total Page:16

File Type:pdf, Size:1020Kb

CONSERVED SOLVENT NETWORKS in GPCR ACTIVATION by ELISE CONSERVED SOLVENT NETWORKS IN GPCR ACTIVATION by ELISE BLANKENSHIP Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Systems Biology and Bioinformatics Program CASE WESTERN RESERVE UNIVERSITY May, 2016 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ELISE BLANKENSHIP Candidate for the degree of Doctor of Philosophy* Committee Chair Dr. Marvin Nieman Committee Member Dr. Mark Chance Committee Member Dr. David T. Lodowski Committee Member Dr. Masaru Miyagi Date of Defense March 3rd, 2016 *We also certify that written approval has been obtained for any proprietary material contained therein Table of Contents List of Tables…………………………………………………………………………...iii List of Figures………………………………………………………………………….iv Acknowledgements…………………………………………………………………..vi List of Abbreviations…………………………………………………………………vii Abstract…………………………………………………………………………………ix 1. Introduction…………………………………………………………………………..1 1.1 Rhodopsin in the Retina…………………………………………………….2 1.2 GPCR Structure……………………………………………………………16 1.3 Computational Analysis of Solvent in Protein Structure………………..33 2. Methods……………………………………………………………………………..37 2.1 Rhodopsin Purification from Bovine Retinal Tissue…………………….37 2.2 Crystallization and Structure Determination of Rhodopsin…………….47 2.3 Analysis of Rhodopsin Crystal Structures……………………………….50 2.4 Analysis of Crystal Structures of Class A GPCRs………………………54 3. The Crystallographic Structure of Rhodopsin………………………………..60 3.1 The High-Resolution Structure of Activated Opsin……………………..60 3.2 Analysis of Previously Determined Rhodopsin Crystal Structures……72 i 4. Water Networks in the Rhodopsin Activation Cycle…………………………77 4.1 Constructing the Rhodopsin Catalytic Cycle…………………………….77 4.2 Water Networks in Ground State and Active State Opsin………………84 4.3 Solvent Subtypes in the Rhodopsin Transmembrane Region…………92 5. Allosteric Networks in GPCR Signaling………………………………………..99 5.1 Conserved Solvent in GPCR Structures…………………………………99 5.2 Whole Network Comparisons of GPCR Solvent Networks…………...106 6. Conclusions and Future Directions…………………………………………...114 6.1 Implications of Solvent Networks for GPCR Signaling………………..114 6.2 Computational Modelling of GPCR-Solvent Interactions……………..115 6.3 Modern Approaches to Drug Discovery………………………………..116 Bibliography…………………………………………………………………………118 ii List of Tables Table 1. Examples of Monogenic Retinal Diseases Linked to Protein Malfunction……………………………………………………………………….9 Table 2. Preparation of Sucrose Solutions for ROS Isolation………………………41 Table 3. Preparation of Kühn’s Buffer………………………………………………..42 Table 4. Data Collection & Refinement Statistics for Activated Opsin…………….50 Table 5. Changes in Water Number in Rhodopsin after Refitting Protocol………..54 Table 6. Class A GPCRs Used for Analysis………………………………………….58 Table 7. Structural Superposition of Selected Bovine Rhodopsin Structures…….67 iii List of Figures Figure 1. Retinal structure and function………………………………………………..4 Figure 2. Class A GPCRs, the rhodopsin family…………………………………….10 Figure 3. Conserved motifs in mammalian rhodopsin essential for activation……18 Figure 4. The phototransduction cascade in mammalian rod cells……………….22 Figure 5. Sucrose gradient construction and purification of crude ROS…………40 Figure 6. The ligand binding site of published rhodopsin structures show evidence for occupancy by detergent……………………………………………………56 Figure 7. Detergent stabilizes an activated state like structure of opsin bound to a high-affinity peptide mimetic of the Gtα-CT…………………………………..64 Figure 8. A networks of waters mediates contacts with Gα-CT in the structure of activated opsin………………………………………………………………….66 Figure 9. Docking of full-length Gt onto activated opsin…………………………….68 Figure 10. Occupancy of the density within the chromophore site is better satisfied by a C9G detergent molecule than all-trans-retinal………………………….71 Figure 11. Entry and exit tunnels in activated opsin…………………………………75 Figure 12. Rhodopsin activation cycle constructed for structures available on the PDB……………………………………………………………………………..80 Figure 13. Ordered solvent employs polar contacts with conserved residues in the ground state and activated state of the receptor……………………………81 Figure 14. Waters found in rhodopsin structures form conserved clusters throughout the activation cycle………………………………………………. 83 iv Figure 15. Waters in rhodopsin structures are found near residues modified in radiolytic footprinting experiments……………………………………………84 Figure 16. Molecular switch regions in activated opsin are bound to ordered water molecules that connect the ligand binding site to G protein binding site…..87 Figure 17. Remodeling of the ionic lock forms a nucleus for organization of water molecules providing a binding site for activation and Gt binding…………..89 Figure 18. Reorganization of the TM solvent network upon attainment of the activated state………………………………………………………………….92 Figure 19. Changes in the network of ordered water molecules stabilize structural changes in the activated state………………………………………………...94 Figure 20. Conserved waters in GPCR structures…………………………………104 Figure 21. Conservation of hydrogen bonding networks connecting conserved motifs important to GPCR activation………………………………………..110 Figure 22. Water mediated hydrogen bonding networks in Class A GPCRs……111 v Acknowledgements My advisor, Dr. David Lodowski, for his continual support and mentorship over the course of my graduate career. My undergraduate advisor, Dr. Nancy Lill, without whom I would not have begun a career in research. My thesis committee and collaborators, Dr. Marvin Nieman, Dr. Masaru Miyagi, Dr. Mark Chance, Dr. Ardeschir Vahedi-Faridi and Dr. Krishna Vukoti, for guidance, feedback, and reassurance. Faculty, staff, classmates and friends at The Ohio State University and Case Western Reserve University, who helped me to learn and grow. My family and Thomas, for unconditional love and support. vi List of Abbreviations Cyclic guanosine monophosphate (cGMP) Correlation coefficient (CC) Double electron-electron resonance spectroscopy (DEER) Dithiothreitrol (DTT) Endoplasmic reticulum (ER) Extracellular loop region (EC) Electron paramagnetic resonance spectroscopy (EPR) Ethylene diamine tetra acetic acid (EDTA) Feature Enhanced Maps (FEMs) Ganglion cell layer (GCL) G protein coupled receptors (GPCRs) Guanosine 5’triphosphate (GTP) Gα transducin C-terminal mimetic peptide (Gα-CT) Lecithin retinol acyltransferase (LRAT) Lipidic cubic phase (LCP) Intracellular loop region (IC) Inner nuclear layer (INL) Inner plexiform layer (IPL) Metarhodpsin II state (MII) Molecular weight cut off (MWCO) Nuclear magnetic resonance spectroscopy (NMR) Outer nuclear layer (ONL) vii Outer plexiform layer (OPL) Protein Data Bank (PDB) Retinal dehydrogenase enzymes (RDHs) Retinal pigment epithelium (RPE) Root mean square deviation (RMSD) Rod outer segment (ROS) Real space R-value z-score (RSRZ) Transmembrane (TM) Time-resolved wide angle x-ray scattering (TR-WAXS) X-ray free-electron laser (XFEL) n-β-D-nonyl-glucoside detergent (C9G) n-β-D-octyl-glucoside detergent (C8G) n-β-D-dodecyl-maltoside (DDM)/(C12M) 3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS) 2-(N-morpholino)ethanesulfonic acid (MES) viii Conserved Solvent Networks in GPCR Activation Abstract by ELISE BLANKENSHIP Rhodopsin, the light-activated G protein coupled receptor (GPCR), has served as a model receptor for GPCRs and their activation, and previous analyses have suggested productive roles for conserved solvent in the transmembrane region. A new structure of photoactivated opsin, stabilized by a peptide corresponding to the Gα C-terminus was determined as a basis for this study. In this structure, an extensive water-mediated hydrogen bond network linking the chromophore binding site to the site of G protein binding is observed, providing connections to conserved motifs essential for GPCR activation. Comparison of this extensive solvent-mediated hydrogen-bonding network with the positions of ordered solvent in earlier crystallographic structures of rhodopsin reveals both static (structural) and dynamic (functional) water-protein interactions present during the activation process. Comparison to structures of other Class A GPCRs reveals waters that are present in conserved locations regardless of activation states, while whole network analysis reveals waters common only to GPCRs in a particular activation state. These analyses strongly support an integral role for the dynamic ordered water network in class A GPCR activation. ix Chapter 1: Introduction To regulate the numerous systems that comprise the body, signals must be sent and received between cells. Integral in this process are cellular receptors, proteins that receive signals and elicit a response. G protein coupled receptors (GPCRs) are membrane-spanning cellular receptors that transduce signal across the plasma membrane in response to a wide variety of ligands. A number of molecules act upon these receptors to communicate between cell types and across tissues (Hofmann and Palczewski, 2015). This ligand binding to receptor regulates a variety of processes, and is responsible for responses ranging from a change in blood pressure to memory storage to vision information processing. GPCRs represent the largest classes of proteins in the human genome, and as such, compounds targeting these receptors to modulate their activity make up close to 35% of all current non-antibiotic therapeutics (Salon et al., 2011). The GPCR rhodopsin is found in the mammalian
Recommended publications
  • Mir-338-3P Is Regulated by Estrogens Through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (Cafs)
    cells Article miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) Adele Vivacqua 1,*, Anna Sebastiani 1, Anna Maria Miglietta 2, Damiano Cosimo Rigiracciolo 1, Francesca Cirillo 1, Giulia Raffaella Galli 1, Marianna Talia 1, Maria Francesca Santolla 1, Rosamaria Lappano 1, Francesca Giordano 1, Maria Luisa Panno 1 and Marcello Maggiolini 1,* 1 Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy; [email protected] (A.S.); [email protected] (D.C.R.); [email protected] (F.C.); [email protected] (G.R.G.); [email protected] (M.T.); [email protected] (M.F.S.); [email protected] (R.L.); [email protected] (F.G.); [email protected] (M.L.P.) 2 Regional HospitalCosenza, 87100 Cosenza, Italy; [email protected] * Correspondence: [email protected] (A.V.); [email protected] (M.M.); Tel.: +39-0984-493-048 (A.V.); +39-0984-493-076 (M.M.) Received: 12 October 2018; Accepted: 7 November 2018; Published: 9 November 2018 Abstract: Estrogens acting through the classic estrogen receptors (ERs) and the G protein estrogen receptor (GPER) regulate the expression of diverse miRNAs, small sequences of non-coding RNA involved in several pathophysiological conditions, including breast cancer. In order to provide novel insights on miRNAs regulation by estrogens in breast tumor, we evaluated the expression of 754 miRNAs by TaqMan Array in ER-negative and GPER-positive SkBr3 breast cancer cells and cancer-associated fibroblasts (CAFs) upon 17β-estradiol (E2) treatment. Various miRNAs were regulated by E2 in a peculiar manner in SkBr3 cancer cells and CAFs, while miR-338-3p displayed a similar regulation in both cell types.
    [Show full text]
  • Profiling G Protein-Coupled Receptors of Fasciola Hepatica Identifies Orphan Rhodopsins Unique to Phylum Platyhelminthes
    bioRxiv preprint doi: https://doi.org/10.1101/207316; this version posted October 23, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Profiling G protein-coupled receptors of Fasciola hepatica 2 identifies orphan rhodopsins unique to phylum 3 Platyhelminthes 4 5 Short title: Profiling G protein-coupled receptors (GPCRs) in Fasciola hepatica 6 7 Paul McVeigh1*, Erin McCammick1, Paul McCusker1, Duncan Wells1, Jane 8 Hodgkinson2, Steve Paterson3, Angela Mousley1, Nikki J. Marks1, Aaron G. Maule1 9 10 11 1Parasitology & Pathogen Biology, The Institute for Global Food Security, School of 12 Biological Sciences, Queen’s University Belfast, Medical Biology Centre, 97 Lisburn 13 Road, Belfast, BT9 7BL, UK 14 15 2 Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 16 17 3 Institute of Integrative Biology, University of Liverpool, Liverpool, UK 18 19 * Corresponding author 20 Email: [email protected] 21 1 bioRxiv preprint doi: https://doi.org/10.1101/207316; this version posted October 23, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 22 Abstract 23 G protein-coupled receptors (GPCRs) are established drug targets. Despite their 24 considerable appeal as targets for next-generation anthelmintics, poor understanding 25 of their diversity and function in parasitic helminths has thwarted progress towards 26 GPCR-targeted anti-parasite drugs.
    [Show full text]
  • Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
    Article Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma Graphical Abstract Authors Scott X. Atwood, Kavita Y. Sarin, ..., Anthony E. Oro, Jean Y. Tang Correspondence [email protected] (A.E.O.), [email protected] (J.Y.T.) In Brief Atwood et al. identify key SMO mutations that confer resistance to SMO inhibitors in basal cell carcinomas (BCC) and show that these mutants respond to aPKC-i/l or GLI2 inhibitors, providing potential approaches for treating BCCs resistant to SMO inhibitors. Highlights Accession Numbers d Functional SMO mutations are detected in the majority of GSE58377 SMO inhibitor-resistant BCCs d Resistance occurs by suppressing drug responsiveness and SMO autoinhibition d SMO mutants explain both intrinsic and acquired tumor resistance d Inhibition of aPKC-i/l or GLI2 bypasses SMO variants to suppress Hedgehog signaling Atwood et al., 2015, Cancer Cell 27, 342–353 March 9, 2015 ª2015 Elsevier Inc. http://dx.doi.org/10.1016/j.ccell.2015.02.002 Cancer Cell Article Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma Scott X. Atwood,1,2 Kavita Y. Sarin,1,2 Ramon J. Whitson,1 Jiang R. Li,1 Geurim Kim,1 Melika Rezaee,1 Mina S. Ally,1 Jinah Kim,1 Catherine Yao,1 Anne Lynn S. Chang,1,3 Anthony E. Oro,1,3,* and Jean Y. Tang1,3,* 1Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA 2Co-first author 3Co-senior author *Correspondence: [email protected] (A.E.O.), [email protected] (J.Y.T.) http://dx.doi.org/10.1016/j.ccell.2015.02.002 SUMMARY Advanced basal cell carcinomas (BCCs) frequently acquire resistance to Smoothened (SMO) inhibitors through unknown mechanisms.
    [Show full text]
  • System, Method and Software for Calculation of a Cannabis Drug Efficiency Index for the Reduction of Inflammation
    International Journal of Molecular Sciences Article System, Method and Software for Calculation of a Cannabis Drug Efficiency Index for the Reduction of Inflammation Nicolas Borisov 1,† , Yaroslav Ilnytskyy 2,3,†, Boseon Byeon 2,3,4,†, Olga Kovalchuk 2,3 and Igor Kovalchuk 2,3,* 1 Moscow Institute of Physics and Technology, 9 Institutsky lane, Dolgoprudny, Moscow Region 141701, Russia; [email protected] 2 Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada; [email protected] (Y.I.); [email protected] (B.B.); [email protected] (O.K.) 3 Pathway Rx., 16 Sandstone Rd. S., Lethbridge, AB T1K 7X8, Canada 4 Biomedical and Health Informatics, Computer Science Department, State University of New York, 2 S Clinton St, Syracuse, NY 13202, USA * Correspondence: [email protected] † First three authors contributed equally to this research. Abstract: There are many varieties of Cannabis sativa that differ from each other by composition of cannabinoids, terpenes and other molecules. The medicinal properties of these cultivars are often very different, with some being more efficient than others. This report describes the development of a method and software for the analysis of the efficiency of various cannabis extracts to detect the anti-inflammatory properties of the various cannabis extracts. The method uses high-throughput gene expression profiling data but can potentially use other omics data as well. According to the signaling pathway topology, the gene expression profiles are convoluted into the signaling pathway activities using a signaling pathway impact analysis (SPIA) method. The method was tested by inducing inflammation in human 3D epithelial tissues, including intestine, oral and skin, and then exposing these tissues to various extracts and then performing transcriptome analysis.
    [Show full text]
  • Tamoxifen Resistance: Emerging Molecular Targets
    International Journal of Molecular Sciences Review Tamoxifen Resistance: Emerging Molecular Targets Milena Rondón-Lagos 1,*,†, Victoria E. Villegas 2,3,*,†, Nelson Rangel 1,2,3, Magda Carolina Sánchez 2 and Peter G. Zaphiropoulos 4 1 Department of Medical Sciences, University of Turin, Turin 10126, Italy; [email protected] 2 Faculty of Natural Sciences and Mathematics, Universidad del Rosario, Bogotá 11001000, Colombia; [email protected] 3 Doctoral Program in Biomedical Sciences, Universidad del Rosario, Bogotá 11001000, Colombia 4 Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge 14183, Sweden; [email protected] * Correspondence: [email protected] (M.R.-L.); [email protected] (V.E.V.); Tel.: +39-01-1633-4127 (ext. 4388) (M.R.-L.); +57-1-297-0200 (ext. 4029) (V.E.V.); Fax: +39-01-1663-5267 (M.R.-L.); +57-1-297-0200 (V.E.V.) † These authors contributed equally to this work. Academic Editor: William Chi-shing Cho Received: 5 July 2016; Accepted: 16 August 2016; Published: 19 August 2016 Abstract: 17β-Estradiol (E2) plays a pivotal role in the development and progression of breast cancer. As a result, blockade of the E2 signal through either tamoxifen (TAM) or aromatase inhibitors is an important therapeutic strategy to treat or prevent estrogen receptor (ER) positive breast cancer. However, resistance to TAM is the major obstacle in endocrine therapy. This resistance occurs either de novo or is acquired after an initial beneficial response. The underlying mechanisms for TAM resistance are probably multifactorial and remain largely unknown. Considering that breast cancer is a very heterogeneous disease and patients respond differently to treatment, the molecular analysis of TAM’s biological activity could provide the necessary framework to understand the complex effects of this drug in target cells.
    [Show full text]
  • G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
    Int. J. Mol. Sci. 2014, 15, 1112-1142; doi:10.3390/ijms15011112 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes Benoît T. Roux 1 and Graeme S. Cottrell 2,* 1 Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK; E-Mail: [email protected] 2 Reading School of Pharmacy, University of Reading, Reading RG6 6UB, UK * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-118-378-7027; Fax: +44-118-378-4703. Received: 4 December 2013; in revised form: 20 December 2013 / Accepted: 8 January 2014 / Published: 16 January 2014 Abstract: G protein-coupled receptors (GPCRs) are important cell signaling mediators, involved in essential physiological processes. GPCRs respond to a wide variety of ligands from light to large macromolecules, including hormones and small peptides. Unfortunately, mutations and dysregulation of GPCRs that induce a loss of function or alter expression can lead to disorders that are sometimes lethal. Therefore, the expression, trafficking, signaling and desensitization of GPCRs must be tightly regulated by different cellular systems to prevent disease. Although there is substantial knowledge regarding the mechanisms that regulate the desensitization and down-regulation of GPCRs, less is known about the mechanisms that regulate the trafficking and cell-surface expression of newly synthesized GPCRs. More recently, there is accumulating evidence that suggests certain GPCRs are able to interact with specific proteins that can completely change their fate and function. These interactions add on another level of regulation and flexibility between different tissue/cell-types.
    [Show full text]
  • Emerging Role of Tumor Cell Plasticity in Modifying Therapeutic Response
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans REVIEW ARTICLE OPEN Emerging role of tumor cell plasticity in modifying therapeutic response Siyuan Qin1, Jingwen Jiang1,YiLu 2,3, Edouard C. Nice4, Canhua Huang1,5, Jian Zhang2,3 and Weifeng He6,7 Resistance to cancer therapy is a major barrier to cancer management. Conventional views have proposed that acquisition of resistance may result from genetic mutations. However, accumulating evidence implicates a key role of non-mutational resistance mechanisms underlying drug tolerance, the latter of which is the focus that will be discussed here. Such non-mutational processes are largely driven by tumor cell plasticity, which renders tumor cells insusceptible to the drug-targeted pathway, thereby facilitating the tumor cell survival and growth. The concept of tumor cell plasticity highlights the significance of re-activation of developmental programs that are closely correlated with epithelial–mesenchymal transition, acquisition properties of cancer stem cells, and trans- differentiation potential during drug exposure. From observations in various cancers, this concept provides an opportunity for investigating the nature of anticancer drug resistance. Over the years, our understanding of the emerging role of phenotype switching in modifying therapeutic response has considerably increased. This expanded knowledge of tumor cell plasticity contributes to developing novel therapeutic strategies or combination therapy regimens using available anticancer drugs, which are likely to
    [Show full text]
  • Subcellular Localization of MC4R with ADCY3 at Neuronal Primary Cilia Underlies a Common Pathway for Genetic Predisposition to Obesity
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nat Genet Manuscript Author . Author manuscript; Manuscript Author available in PMC 2018 July 08. Published in final edited form as: Nat Genet. 2018 February ; 50(2): 180–185. doi:10.1038/s41588-017-0020-9. Subcellular localization of MC4R with ADCY3 at neuronal primary cilia underlies a common pathway for genetic predisposition to obesity Jacqueline E. Siljee1,*, Yi Wang1,*, Adelaide A. Bernard1, Baran A. Ersoy1, Sumei Zhang1, Aaron Marley2, Mark Von Zastrow2, Jeremy F. Reiter3, and Christian Vaisse1,** 1Department of Medicine and Diabetes Center, University of California, San Francisco, California, USA 2Department of Psychiatry and Cellular & Molecular Pharmacology, University of California, San Francisco, California, USA 3Department of Biochemistry and Biophysics, Cardiovascular Research Institute, University of California, San Francisco, California, USA MAIN TEXT Most monogenic cases of obesity in humans have been linked to mutations in genes of the leptin-melanocortin pathway. Specifically, mutations in the Melanocortin-4 Receptor (MC4R), account for 3–5% of all severe obesity cases in humans1–3. Recently, adenylate cyclase 3 (ADCY3) mutations have been implicated in obesity4,5. ADCY3 is expressed at the primary cilia of neurons6, organelles that function as hubs for select signaling pathways. Mutations that disrupt the functions of primary cilia cause ciliopathies, rare recessive pleiotropic diseases, of which obesity is a cardinal manifestation7. We demonstrate that MC4R co-localizes with ADCY3 at the primary cilium of a subset of hypothalamic neurons, that obesity-associated MC4R mutations can impair ciliary localization and that inhibition of adenylyl-cyclase signaling at the primary cilia of these neurons increases body weight.
    [Show full text]
  • Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics
    cancers Review Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics James M. Kilgour , Justin L. Jia and Kavita Y. Sarin * Department of Dermatology, Stanford University School of Medcine, Stanford, CA 94305, USA; [email protected] (J.M.K.); [email protected] (J.L.J.) * Correspondence: [email protected] Simple Summary: Basal cell carcinoma is the most common human cancer worldwide. The molec- ular basis of BCC involves an interplay of inherited genetic susceptibility and somatic mutations, commonly induced by exposure to UV radiation. In this review, we outline the currently known germline and somatic mutations implicated in the pathogenesis of BCC with particular attention paid toward affected molecular pathways. We also discuss polymorphisms and associated phenotypic traits in addition to active areas of BCC research. We finally provide a brief overview of existing non-surgical treatments and emerging targeted therapeutics for BCC such as Hedgehog pathway inhibitors, immune modulators, and histone deacetylase inhibitors. Abstract: Basal cell carcinoma (BCC) is a significant public health concern, with more than 3 million cases occurring each year in the United States, and with an increasing incidence. The molecular basis of BCC is complex, involving an interplay of inherited genetic susceptibility, including single Citation: Kilgour, J.M.; Jia, J.L.; Sarin, nucleotide polymorphisms and genetic syndromes, and sporadic somatic mutations, often induced K.Y. Review of the Molecular Genetics of Basal Cell Carcinoma; by carcinogenic exposure to UV radiation. This review outlines the currently known germline and Inherited Susceptibility, Somatic somatic mutations implicated in the pathogenesis of BCC, including the key molecular pathways Mutations, and Targeted affected by these mutations, which drive oncogenesis.
    [Show full text]
  • Supporting Information
    Supporting Information Supporting Figures Fig. S1. Influence of the number of ligand samples on the model performance. (A) The improvement in r2 of the model based on the top-300 features selected from 1,024 bits against the baseline model. (B) The improvement in r2 of the optimal model (highlighted in boldface in Table 1) against the model based on the top-300 features selected from 1024 bits. Group I: GPCR datasets with more than 600 ligands, i.e., P08908, Q9Y5N1, P28335, P35372, Q99705, P0DMS8, Q16602, P51677, P48039; Group II: GPCR datasets with fewer than 600 ligands, i.e., Q9H228, Q8TDU6, Q8TDS4, Q9HC97, P41180, Q14833, Q99835. Supporting Tables Table S1. Description of datasets used in this study UniProt Gene # of # of Protein Name Class Subfamily Clinical Significance ID Name Ligands Controls 5-hydroxytryptamine Blood pressure, heart rate, antidepressant, anxiolytic, P08908 HTR1A A Aminergic receptors 4322 850 receptor 1A schizophrenia and Parkinson (H Ito, 1999) Q9Y5N1 HRH3 Histamine H3 receptor A Aminergic receptors 3644 700 Cognitive disorders (Esbenshade, et al., 2008) 5-hydroxytryptamine mood, anxiety, feeding, and reproductive P28335 HTR2C A Aminergic receptors 3286 650 receptor 2C behavior(Heisler, et al., 2007) Morphine-induced analgesia and itching (Liu, et al., P35372 OPRM1 Mu-type opioid receptor A Peptide receptors 4591 900 2011) Melanin-concentrating Appetite, anxiety and depression (Rivera, et al., Q99705 MCHR1 A Peptide receptors 3663 700 hormone receptors 1 2008) Bronchial asthma(Jacobson, et al., 2008)and P0DMS8
    [Show full text]
  • Multi-Functionality of Proteins Involved in GPCR and G Protein Signaling: Making Sense of Structure–Function Continuum with In
    Cellular and Molecular Life Sciences (2019) 76:4461–4492 https://doi.org/10.1007/s00018-019-03276-1 Cellular andMolecular Life Sciences REVIEW Multi‑functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder‑based proteoforms Alexander V. Fonin1 · April L. Darling2 · Irina M. Kuznetsova1 · Konstantin K. Turoverov1,3 · Vladimir N. Uversky2,4 Received: 5 August 2019 / Revised: 5 August 2019 / Accepted: 12 August 2019 / Published online: 19 August 2019 © Springer Nature Switzerland AG 2019 Abstract GPCR–G protein signaling system recognizes a multitude of extracellular ligands and triggers a variety of intracellular signal- ing cascades in response. In humans, this system includes more than 800 various GPCRs and a large set of heterotrimeric G proteins. Complexity of this system goes far beyond a multitude of pair-wise ligand–GPCR and GPCR–G protein interactions. In fact, one GPCR can recognize more than one extracellular signal and interact with more than one G protein. Furthermore, one ligand can activate more than one GPCR, and multiple GPCRs can couple to the same G protein. This defnes an intricate multifunctionality of this important signaling system. Here, we show that the multifunctionality of GPCR–G protein system represents an illustrative example of the protein structure–function continuum, where structures of the involved proteins represent a complex mosaic of diferently folded regions (foldons, non-foldons, unfoldons, semi-foldons, and inducible foldons). The functionality of resulting highly dynamic conformational ensembles is fne-tuned by various post-translational modifcations and alternative splicing, and such ensembles can undergo dramatic changes at interaction with their specifc partners.
    [Show full text]
  • Melanopsin: an Opsin in Melanophores, Brain, and Eye
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 340–345, January 1998 Neurobiology Melanopsin: An opsin in melanophores, brain, and eye IGNACIO PROVENCIO*, GUISEN JIANG*, WILLEM J. DE GRIP†,WILLIAM PA¨R HAYES‡, AND MARK D. ROLLAG*§ *Department of Anatomy and Cell Biology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814; †Institute of Cellular Signaling, University of Nijmegen, 6500 HB Nijmegen, The Netherlands; and ‡Department of Biology, The Catholic University of America, Washington, DC 20064 Edited by Jeremy Nathans, Johns Hopkins University School of Medicine, Baltimore, MD, and approved November 5, 1997 (received for review September 16, 1997) ABSTRACT We have identified an opsin, melanopsin, in supernatants subjected to SDSyPAGE analysis and subse- photosensitive dermal melanophores of Xenopus laevis. Its quent electroblotting onto a poly(vinylidene difluoride) mem- deduced amino acid sequence shares greatest homology with brane. The blot was probed with a 1:2,000 dilution of antisera cephalopod opsins. The predicted secondary structure of (CERN 886) raised against bovine rhodopsin and detected by melanopsin indicates the presence of a long cytoplasmic tail enhanced chemiluminescence. with multiple putative phosphorylation sites, suggesting that cDNA Library Screen. A X. laevis dermal melanophore this opsin’s function may be finely regulated. Melanopsin oligo(dT) cDNA library was screened with a mixture of mRNA is expressed in hypothalamic sites thought to contain 32P-labeled probes. Probes were synthesized by random prim- deep brain photoreceptors and in the iris, a structure known ing of TA-cloned (Invitrogen) fragments of X. laevis rhodopsin to be directly photosensitive in amphibians. Melanopsin mes- (7) (759 bp) and violet opsin (8) (279 bp) cDNAs.
    [Show full text]